Avecho Biotechnology Limited (ASX:AVE)
0.0120
+0.0010 (9.09%)
Apr 29, 2026, 4:13 PM AEST
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of 40.41 million as of April 28, 2026. Its market cap has increased by 218.75% in one year.
Market Cap
40.41M
Enterprise Value
35.76M
Revenue
1.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has increased from 39.36M to 40.41M, an increase of 2.67%. That is a compound annual growth rate of 0.09%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 38.25M |
| Imugene | 44.63M |
| EZZ Life Science Holdings | 35.54M |
| Proteomics International Laboratories | 46.25M |
| Entropy Neurodynamics | 53.85M |
| Prescient Therapeutics | 56.78M |
| Neurizon Therapeutics | 63.08M |
| Noxopharm | 23.35M |